Xingxing Qi - Publications

Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 08, 2019

Oliguric acute kidney injury after microwave ablation of large liver tumors: incidence and preventive measures.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: September 12, 2018

Clinical outcome in elderly Chinese patients with primary hepatocellular carcinoma treated with percutaneous microwave coagulation therapy (PMCT): A Strobe-compliant observational study.

Journal: Medicine

Published: September 02, 2018

Feasibility, safety, and efficacy of ultrasound-guided percutaneous microwave ablation for giant hepatic hemangioma.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: August 23, 2018

Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma: clinical outcomes and prognostic factors.

Journal: Journal of cancer research and clinical oncology

Published: September 01, 2016

Long noncoding RNA ZNFX1-AS1 suppresses growth of hepatocellular carcinoma cells by regulating the methylation of miR-9.

Journal: OncoTargets and therapy

Published: August 31, 2016

Hepatocellular carcinoma: thyroid hormone promotes tumorigenicity through inducing cancer stem-like cell self-renewal.

Journal: Scientific reports

Published: February 11, 2016

Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro.

Journal: Molecular medicine reports

Published: September 08, 2015